CSIMarket
 


Innoviva, inc.  (INVA)
Other Ticker:  
 
 

INVA's Income from Cont. Operations Growth by Quarter and Year

Innoviva, inc.'s Income from Cont. Operations results by quarter and year




INVA Income from Cont. Operations (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter December - 269.22 58.51 25.47
III Quarter September 47.05 50.17 23.77 15.03
II Quarter June 46.06 56.62 35.15 14.60
I Quarter March 40.02 30.33 16.85 4.44
FY   133.13 406.34 134.28 59.54



INVA Income from Cont. Operations third quarter 2019 Y/Y Growth Comment
Innoviva, inc. reported decrease in Income from Cont. Operations in the third quarter by -6.22% to $ 47.05 millions, from the same quarter in 2018.
The decrease in the third quarter Innoviva, inc.'s Income from Cont. Operations compares unfavorably to the Company's average Income from Cont. Operations rise of 33.4%.

Looking into third quarter results within Major Pharmaceutical Preparations industry 10 other companies have achieved higher Income from Cont. Operations growth. While Innoviva, inc.' s Income from Cont. Operations decline of -6.22% ranks overall at the positon no. 718 in the third quarter.




INVA Income from Cont. Operations ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter December - 360.13 % 129.72 % 492.33 %
III Quarter September -6.22 % 111.06 % 58.15 % -
II Quarter June -18.65 % 61.08 % 140.75 % -
I Quarter March 31.95 % 80 % 279.5 % -
FY   - 202.61 % 125.53 % -

Financial Statements
Innoviva, inc.'s third quarter 2019 Income from Cont. Operations $ 47.05 millions INVA's Income Statement
Innoviva, inc.'s third quarter 2018 Income from Cont. Operations $ 50.17 millions Quarterly INVA's Income Statement
New: More INVA's historic Income from Cont. Operations Growth >>


INVA Income from Cont. Operations (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter December - 436.62 % 146.15 % 69.46 %
III Quarter September 2.15 % -11.39 % -32.38 % 2.95 %
II Quarter June 15.09 % 86.68 % 108.61 % 228.83 %
I Quarter March -85.13 % -48.16 % -33.84 % 3.26 %
FY (Year on Year)   - 202.61 % 125.53 % -




Income from Cont. Operations third quarter 2019 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #11
Healthcare Sector #48
Overall #718

Income from Cont. Operations Y/Y Growth Statistics
High Average Low
107.71 % 33.4 % -0.77 %
(Dec 31 2018)   (Sep 30 2019)
Income from Cont. Operations third quarter 2019 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #11
Healthcare Sector #48
Overall #718
Income from Cont. Operations Y/Y Growth Statistics
High Average Low
107.71 % 33.4 % -0.77 %
(Dec 31 2018)   (Sep 30 2019)

Income from Cont. Operations by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Innoviva, inc.'s Q/Q Income from Cont. Operations Growth


Income from Cont. Operations Q/Q Growth Statistics
High Average Low
436.64 % 59.28 % -85.13 %
(Dec 31 2018)  


INVA's III. Quarter Q/Q Income from Cont. Operations Comment
Innoviva, inc. achieved in the III. Quarter 2019 below company average Income from Cont. Operations growth of 2.15% quarter on quarter, to $ 47.05 millions.

III. Quarter 2019 INVA's performance were contradictory, although below the ordinary increase of 59.28 %, yet it demonstrates a quite acceleration relative to the -11.39% in the III. Quarter 2018.

Within Major Pharmaceutical Preparations industry 4 other companies have achieved higher Income from Cont. Operations quarter on quarter growth. While Innoviva, inc.'s Income from Cont. Operations growth quarter on quarter, overall rank is 575.


Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #5
Healthcare Sector #31
Overall #575
Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #5
Healthcare Sector #31
Overall #575
Income from Cont. Operations Q/Q Growth Statistics
High Average Low
436.64 % 59.28 % -85.13 %
(Dec 31 2018)  


INVA's III. Quarter Q/Q Income from Cont. Operations Comment
Innoviva, inc. achieved in the III. Quarter 2019 below company average Income from Cont. Operations growth of 2.15% quarter on quarter, to $ 47.05 millions.

III. Quarter 2019 Innoviva, inc.'s Income from Cont. Operations sequential growth appear to be a mixed bag, although below the regular, yet it demonstrates absolute acceleration measured to the -11.39% in the III. Quarter 2018.

Within Major Pharmaceutical Preparations industry 4 other companies have achieved higher Income from Cont. Operations quarter on quarter growth. While Innoviva, inc.'s Income from Cont. Operations growth quarter on quarter, overall rank is 575.


Innoviva, inc.'s 12 Months Income from Cont. Operations Growth Year on Year


Income from Cont. Operations TTM Growth

12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
12 Months Ending
(Mar 31 2019)
12 Months Ending
(Dec 31 2018)
12 Months Ending
(Sep 30 2018)
Cumulative Income from Cont. Operations 12 Months Ending $ 402.35 $ 0.00 $ 416.02 $ 406.33 $ 195.63
Y / Y Income from Cont. Operations Growth (TTM) 105.67 % - 181.55 % 202.62 % 93.25 %
Year on Year Income from Cont. Operations Growth Overall Ranking # 139 # 0 # 0 # #
Seqeuential Income from Cont. Operations Change (TTM) -0.77 % - 2.38 % 107.71 % 15.6 %
Seq. Income from Cont. Operations Growth (TTM) Overall Ranking # 1192 # 0 # 0 # #




Cumulative Income from Cont. Operations growth Comment
Although Innoviva, inc.'s Annual Income from Cont. Operations growth year on year were below company's average 166.02% , Income from Cont. Operations announced in the Sep 30 2019 period, show improvement in Income from Cont. Operations trend, to cumulative trailing twelve month growth of 105.67% year on year, from % in Jun 30 2019.

Among companies within the Healthcare sector 19 other companies have achieved higher trailing twelve month Income from Cont. Operations growth. While Income from Cont. Operations growth total ranking has deteriorated compare to previous quarter from 0 to 139.

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
107.71 %
33.4 %
-0.77 %
 

Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 16
Healthcare Sector # 20
Overall # 139

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
393.33 %
166.02 %
82.96 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 16
Sector # 82
S&P 500 # 1192
Cumulative Income from Cont. Operations growth Comment
Although Innoviva, inc.'s Annual Income from Cont. Operations growth year on year were below company's average 166.02% , Income from Cont. Operations announced in the Sep 30 2019 period, show improvement in Income from Cont. Operations trend, to cumulative trailing twelve month growth of 105.67% year on year, from % in Jun 30 2019.

Among companies within the Healthcare sector 19 other companies have achieved higher trailing twelve month Income from Cont. Operations growth. While Income from Cont. Operations growth total ranking has deteriorated compare to previous quarter from 0 to 139.

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
107.71 %
33.4 %
-0.77 %
 


Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 16
Healthcare Sector # 20
Overall # 139

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
393.33 %
166.02 %
82.96 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 16
Sector # 82
S&P 500 # 1192




Other Income from Cont. Operations Growth
Major Pharmaceutical Preparations Industry Income from Cont. Operations Growth Trends and Statistics
Healthcare Sector Income from Cont. Operations Growth Statistics
Income from Cont. Operations Growth Trends for overall market
INVA's Income from Cont. Operations Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Income from Cont. Operations Growth
Lowest Ranking Income from Cont. Operations Growth
Income from Cont. Operations Growth for INVA's Competitors
Income from Cont. Operations Growth for Innoviva, inc.'s Suppliers
Income from Cont. Operations Growth for INVA's Customers

You may also want to know
INVA's Annual Growth Rates INVA's Profitability Ratios INVA's Asset Turnover Ratio INVA's Dividend Growth
INVA's Roe INVA's Valuation Ratios INVA's Financial Strength Ratios INVA's Dividend Payout Ratio
INVA's Roa INVA's Inventory Turnover Ratio INVA's Growth Rates INVA's Dividend Comparisons



Companies with similar Income from Cont. Operations growth for the quarter ending Sep 30 2019 within Healthcare SectorY/Y Change %Income from Cont. Operations for the quarter ending Sep 30 2019
Quest Diagnostics Inc -0.44 %$ -0.441 millions
Dexcom, Inc. -1.72 %$ -1.717 millions
Merck & Co., Inc. -2.60 %$ -2.605 millions
Procyon Corp -3.94 %$ -3.941 millions
Innoviva, inc. -6.21 %$ -6.211 millions
Radnet, Inc. -11.80 %$ -11.796 millions
Masimo Corp -14.08 %$ -14.076 millions
Hca Healthcare, Inc. -14.73 %$ -14.732 millions
Bio-techne Corp -17.27 %$ -17.267 millions
Pro Dex Inc -18.16 %$ -18.162 millions
Stryker Corp -21.02 %$ -21.017 millions
Zynex Inc -21.54 %$ -21.536 millions
Magellan Health, inc. -21.63 %$ -21.628 millions
Ani Pharmaceuticals Inc -22.67 %$ -22.672 millions
Exelixis, Inc. -23.04 %$ -23.042 millions
Bristol Myers Squibb Co -28.56 %$ -28.556 millions
Healthcare Services Group Inc -29.68 %$ -29.679 millions
Laboratory Corp Of America Holdings -30.72 %$ -30.721 millions
Nuvasive Inc -30.85 %$ -30.855 millions
Jazz Pharmaceuticals Plc -31.50 %$ -31.504 millions
Standard Diversified Inc. -36.36 %$ -36.364 millions
Petmed Express Inc -38.01 %$ -38.012 millions
Techcare Corp. -38.18 %$ -38.184 millions
Amphastar Pharmaceuticals, Inc. -39.11 %$ -39.109 millions
Universal Health Services Inc -42.32 %$ -42.321 millions
Tivity Health, Inc. -45.10 %$ -45.104 millions
Utah Medical Products Inc -45.21 %$ -45.209 millions
Jrsis Health Care Corp -46.24 %$ -46.238 millions
Psychemedics Corp -46.90 %$ -46.902 millions
Biotelemetry, Inc. -48.23 %$ -48.234 millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

GURE's Profile

Stock Price

GURE's Financials

Business Description

Fundamentals

Charts & Quotes

GURE's News

Suppliers

GURE's Competitors

Customers & Markets

Economic Indicators

GURE's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071